RAFAEL HOLDINGS, INC. Goodwill, Acquired During Period
RAFAEL HOLDINGS, INC. (RFL) reported Goodwill, Acquired During Period of $3.05 million for the 12-month period ending 2024-07-31, per its 10-K/A filed 2024-12-20.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2024-12-20
- RAFAEL HOLDINGS, INC. goodwill, acquired during period for the quarter ending 2024-07-31 was -$521.00K.
- RAFAEL HOLDINGS, INC. goodwill, acquired during period for fiscal 2024 was $3.05M.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|
| 2024-07-31 | -$521.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | $3.05M 10-K/A · filed 2024-12-20 | |
| 2024-04-30 | $3.57M 10-Q · filed 2024-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |